Citigroup Inc. reissued their buy rating on shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in a research note released on Monday, July 24th. The firm currently has a $1,078.00 price target on the medical equipment provider’s stock, up from their previous price target of $917.00.
Other analysts also recently issued reports about the company. Royal Bank Of Canada restated a hold rating and set a $1,000.00 target price on shares of Intuitive Surgical in a research note on Friday, July 21st. Stifel Nicolaus lifted their price target on Intuitive Surgical from $800.00 to $850.00 and gave the stock a buy rating in a research note on Wednesday, April 19th. Canaccord Genuity reiterated a buy rating and issued a $870.00 price target (up from $800.00) on shares of Intuitive Surgical in a research note on Wednesday, April 19th. Goldman Sachs Group, Inc. (The) began coverage on Intuitive Surgical in a research note on Tuesday, May 16th. They issued a buy rating and a $1,000.00 price target for the company. Finally, Zacks Investment Research downgraded Intuitive Surgical from a buy rating to a hold rating in a research note on Thursday, April 20th. Seven equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $980.03.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 942.25 on Monday. Intuitive Surgical has a 52 week low of $610.71 and a 52 week high of $974.66. The stock has a market capitalization of $35.00 billion, a PE ratio of 45.13 and a beta of 0.39. The company’s 50 day moving average price is $941.15 and its 200-day moving average price is $833.76. Shares of Intuitive Surgical are scheduled to split on the morning of Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly created shares will be distributed to shareholders after the market closes on Wednesday, August 30th.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating the consensus estimate of $5.79 by $0.16. The company had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The company’s revenue was up 12.8% on a year-over-year basis. During the same period last year, the firm earned $5.62 earnings per share. Equities research analysts predict that Intuitive Surgical will post $23.86 EPS for the current year.
In other Intuitive Surgical news, Director Amal M. Johnson sold 1,000 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $917.27, for a total value of $917,270.00. Following the transaction, the director now owns 3,787 shares in the company, valued at $3,473,701.49. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Mark J. Meltzer sold 3,000 shares of Intuitive Surgical stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $887.09, for a total transaction of $2,661,270.00. Following the completion of the transaction, the senior vice president now owns 3,046 shares in the company, valued at approximately $2,702,076.14. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,065 shares of company stock worth $31,659,090. 2.50% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of ISRG. BlackRock Inc. boosted its position in Intuitive Surgical by 2,770.9% in the first quarter. BlackRock Inc. now owns 2,846,621 shares of the medical equipment provider’s stock valued at $2,181,851,000 after buying an additional 2,747,465 shares during the last quarter. FMR LLC boosted its position in Intuitive Surgical by 19.6% in the second quarter. FMR LLC now owns 2,724,964 shares of the medical equipment provider’s stock valued at $2,548,849,000 after buying an additional 447,397 shares during the last quarter. Edgewood Management LLC boosted its position in Intuitive Surgical by 38.8% in the first quarter. Edgewood Management LLC now owns 919,617 shares of the medical equipment provider’s stock valued at $704,859,000 after buying an additional 257,165 shares during the last quarter. Waddell & Reed Financial Inc. boosted its position in Intuitive Surgical by 77.3% in the first quarter. Waddell & Reed Financial Inc. now owns 417,863 shares of the medical equipment provider’s stock valued at $320,280,000 after buying an additional 182,139 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in Intuitive Surgical by 57.5% in the second quarter. Renaissance Technologies LLC now owns 307,100 shares of the medical equipment provider’s stock valued at $287,252,000 after buying an additional 112,130 shares during the last quarter. Hedge funds and other institutional investors own 96.84% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.